IL6 and colorectal carcinoma: We evaluated the expression of IL6 in serum and the PIK3CAH1047R mutation in serum‐derived exosomes in fifty‐five patients with CRC, of whom twenty‐nine had TNM stages I–II and twenty‐six had TNM stages III–IV.